387 related articles for article (PubMed ID: 19100843)
1. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping.
Ulmer S; Hartwigsen G; Riedel C; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2010 Feb; 49(3):2158-62. PubMed ID: 19900562
[TBL] [Abstract][Full Text] [Related]
3. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
4. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery.
Senft C; Seifert V; Hermann E; Franz K; Gasser T
Neurosurgery; 2008 Oct; 63(4 Suppl 2):257-66; discussion 266-7. PubMed ID: 18981831
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
9. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction.
Lupo JM; Lee MC; Han ET; Cha S; Chang SM; Berger MS; Nelson SJ
J Magn Reson Imaging; 2006 Sep; 24(3):520-9. PubMed ID: 16888776
[TBL] [Abstract][Full Text] [Related]
11. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
[TBL] [Abstract][Full Text] [Related]
12. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative neurophysiological monitoring in an open low-field magnetic resonance imaging system: clinical experience and technical considerations.
Szelényi A; Gasser T; Seifert V
Neurosurgery; 2008 Oct; 63(4 Suppl 2):268-75; discussion 275-6. PubMed ID: 18981832
[TBL] [Abstract][Full Text] [Related]
14. How to overcome the limitations to determine the resection margin of pituitary tumours with low-field intra-operative MRI during trans-sphenoidal surgery: usefulness of Gadolinium-soaked cotton pledgets.
Ahn JY; Jung JY; Kim J; Lee KS; Kim SH
Acta Neurochir (Wien); 2008 Aug; 150(8):763-71; discussion 771. PubMed ID: 18594752
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
[TBL] [Abstract][Full Text] [Related]
16. Comparison of perfusion MRI by flow-sensitive alternating inversion recovery and dynamic susceptibility contrast in rats with permanent middle cerebral artery occlusion.
Hofmeijer J; Schepers J; van der Worp HB; Kappelle LJ; Nicolay K
NMR Biomed; 2005 Oct; 18(6):390-4. PubMed ID: 16075409
[TBL] [Abstract][Full Text] [Related]
17. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients.
Hunsche S; Sauner D; Schreiber WG; Oelkers P; Stoeter P
J Magn Reson Imaging; 2002 Aug; 16(2):137-46. PubMed ID: 12203760
[TBL] [Abstract][Full Text] [Related]
18. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
Lüdemann L; Warmuth C; Plotkin M; Förschler A; Gutberlet M; Wust P; Amthauer H
Eur J Radiol; 2009 Jun; 70(3):465-74. PubMed ID: 18359598
[TBL] [Abstract][Full Text] [Related]
19. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
